Jan has more than 30 years of experience in managing all components of clinical research from protocol development through commercial regulatory approval, both in the U.S. and internationally. She has worked for Medtronic, Cardiovascular Systems, EnteroMedics, Terumo CardioVascular, Coloplast, Neuros Medical, and Respithera. She also developed clinical compliance and clinical operations organizations for medical device companies and implemented global regulatory policies and procedures. Jan graduated from Bethesda Nursing School and Bethel University for businessmanagement, with honors in both programs.
Bob served as CFO for Nivagen Pharmaceutical, Sonoma Pharmaceuticals, GAF Corporation, PenwestInc., Cerus Corporation, Ameron Corporation, and Bugle Boy. He also served as Treasurer for Mead Corporationand as Vice President of investment banking at Blyth, Eastman Dillon & Co. His specialty in recent years is funding and commercializing unique and effective medical technologies. Bob has a B.A. from Stanford in Economics and Industrial Engineering and an MBA from Columbia University.
Rona has more than 30 years of experience in managing design control, quality systems, and reliability for medical devices. She has worked for Johnson & Johnson, Covidien, Stryker, Boston Scientific and Genentech. Rona is responsible for AWCT’s compliance with FDA QS and GMP regulations. She also manages the two CMOs who design and manufacture our device. Rona has a B.S. in electrical engineering with highest distinction from Chongquing University in China and an M.S. in in Electrical Power System Operation and Optimization from the University of Texas.
Tao has 30 years of experience in process engineering, manufacturing engineering and supplier engineering. Prior to joining AWCT, he worked for Intuitive Surgical, Genentech, Alexa Pharmaceuticals, Sanmina-SCI Medical Devices, and Applied Materials. He has a B.S. in mechanical engineering Shanghai Jiao Tong University and an M.S. in mechanical engineering from the University of South Carolina.
Tom F. Lue, MD, ScD (Hon), FACS – Co-founder;Principal Scientific Advisor.
Dr. Lue is Professor and Emil Tanagho Endowed Chair in Clinical Urology at the University of California San Francisco and medical director of the Knuppe Molecular Urology Laboratory. Dr. Lue is an internationally recognized expert on treatment of male sexual dysfunction and a pioneer in surgical methods to treat refractory ED. His research team proved that PDE5 inhibitors enhance erection in animals, providing the scientific basis for Viagra, Levitra and Cialis. He is also an expert on incontinence and developed the first animal model of female stress urinary incontinence,now used widely to study potential treatments. He is co-inventor of the sacral stimulation method of treating urge incontinence, the technology underlying Medtronic’s Interstim product line. Dr. Lue graduated with highest honors from the Kaohsiung Medical University in Taiwan and completed his urologic training at the State University of New York Downstate Medical Center. He has authored or co-authored twelve books and more than 380 publications. He is the recipient of numerous honors, including the Gold Cystoscope Award from the American Urological Association and an award for most innovative research from the American Foundation of Urologic Disease